AC Immune bags FDA fast track designation

New targets for incurable blood cancer

SynaptixBio Ltd and Evotec SE expand collaboration

Von der Leyen: no mention of biotechnology

Scientists prevent transplant rejection

Draupnir Bio ApS raises further equity

CordenPharma invests €900m in peptide patform expansion

Catalym raises US$150m

Sensorion achieves milestones in Phase II trial